Perspective Therapeutics Inc. Revenue 2020–2025
Perspective Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Perspective Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0.
- Perspective Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Perspective Therapeutics Inc. annual revenue for 2025 was 0.
- Perspective Therapeutics Inc. annual revenue for 2024 was 0.
- Perspective Therapeutics Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Perspective Therapeutics Inc. annual revenue for 2022 was 10.8 M.
Perspective Therapeutics Inc. (CATX) — Frequently Asked Questions
Perspective Therapeutics Inc. (CATX) is a publicly traded US company. It has a market capitalization of $218M. Explore CATX's stock price, financial statements, earnings history, margins and key ratios below.
What is Perspective Therapeutics Inc.'s market cap?
Perspective Therapeutics Inc. (CATX) has a market capitalization of $218M.
What is the CATX stock price?
CATX trades at $2.95 (-1.67% on the day).
Is CATX profitable?
In fiscal 2025, Perspective Therapeutics Inc. reported net income of -$103M.